Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 225 of 248 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/01/20
End: 11/30/23
Due: 11/30/24
Phase: N/A
Priority: Normal
Start: 07/31/24
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 09/30/06
End: 12/31/07
Due: 12/31/08
Phase: N/A
Priority: Normal
Start: 11/30/08
End: 12/31/09
Due: 12/31/10
Phase: N/A
Priority: Normal
Start: 03/31/08
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 05/01/20
End: 02/02/22
Due: 02/02/23
Phase: N/A
Priority: Normal
Start: 12/31/08
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 09/15/18
End: 10/15/19
Due: 10/15/20
Phase: N/A
Priority: Normal
Start: 01/31/11
End: 01/31/14
Due: 01/31/15
Phase: N/A
Priority: Normal
Start: 11/01/24
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 09/30/05
End: 02/28/06
Due: 02/28/07
Correlation Between CYP2C19 Genotype, Level Of Clopidogrel Metabolite And Platelet Inhibition Status
Phase: N/A
Priority: Normal
Start: 09/30/10
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 08/31/13
End: 07/31/14
Due: 07/31/15
Phase: N/A
Priority: Normal
Start: 05/01/13
End: 05/31/20
Due: 05/31/21
Phase: N/A
Priority: Normal
Start: 03/31/15
End: 06/30/17
Due: 06/30/18
Phase: N/A
Priority: Normal
Start: 11/30/08
End: 08/31/09
Due: 08/31/10
Phase: N/A
Priority: Normal
Start: 05/31/15
End: 11/30/17
Due: 11/30/18
Phase: N/A
Priority: Normal
Start: 02/29/12
End: 06/30/14
Due: 06/30/15
Phase: N/A
Priority: Normal
Start: 06/30/07
End: 08/31/08
Due: 08/31/09
Phase: N/A
Priority: Normal
Start: 05/15/18
End: 09/15/21
Due: 09/15/22
Phase: N/A
Priority: Normal
Start: 04/01/24
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 10/31/06
End: 08/31/08
Due: 08/31/09
Phase: N/A
Priority: Normal
Start: 09/01/15
End: 05/04/20
Due: 05/04/21
Phase: N/A
Priority: Normal
Start: 12/31/09
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/01/23
End: 12/31/25
Due: 12/31/26